The IASMED 2025 Scientific Seminar “Moving Forward: Indonesian Clinical Trial” was held on Saturday, January 18, 2025, by Indonesia’s clinical trial association, The Indonesian Association for The Study of Medicines (IASMED).
This seminar is aimed to provide IASMED members to update information regarding clinical trial sites in order to improve the quality and quantity of clinical trials in Indonesia, especially multi-regional clinical trials (MRCT). There are two sessions on this scientific seminar. The first session consists of 4 speakers that are apt. Indri Rooslamiati, M.Sc as the Head of BB Binomika, Prof. dr. Taruna Ikrar, M.Biomed., Ph.D – Head of BPOM, Prof. Young Joo Par as Vice President DIA Korea, Singapore, and Southeast Asia and Dra. Endang W. Hoyaranda as the head of IASMED. The second session is a panel discussion with the clinical trial stakeholders. One of the main speaker is Prof. dr. Taruna Ikrar, M.Biomed., Ph.D – Head of BPOM. He said that BPOM will continue to supervise the clinical trial center’s infrastructure and personnel and keep fostering collaboration and integration among academia, business, and governance. There is also a networking session on this seminar where IASMED members can meet representatives from Clinical Research Unit of many hospitals and other clinical trials collaborators.
In this event, also was attended bt clinical trial professionals such as Prof. Dr. Rianto Setiabudy, Prof. Arini Setiawati, and Prof. Young Joo Park, Vice President of the Drug Information Association (DIA) Korea, Singapore, and Southeast Asia, Indri Rooslamiati, M.Sc., Apt. Head of BB Binomika, CRUs, sponsors, global and local CROs.
In addition to the scientific agenda,during this eventalso celebrated the election of the IASMED chairs, including the new IASMED committee chairs and IASMED supervisory board chair. May IASMED continued success and contribute more to enhancing the quality and quantity of clinical trials in Indonesia.
Prodia the CRO, believes that this marked as an excellent time for clinical trials in Indonesia. Prodia the CRO is a Contract Research Organization (CRO) based in Indonesia which provides GCP-based Clinical Trial supports through our integrated and wide range of services. Prodia the CRO has accumulated many experiences providing services to local as well as multinational companies with commitment to reach quality through qualified and dedicated resources. It provides customers in GCP trials with competitive costs, firm timeliness, and high compliance to ICH-GCP guidelines(CDF).
